GSK Shifts Focus After Haleon Spinoff
Sydney Otomancek2022-07-26T01:34:27-04:00July 26th, 2022|Categories: Featured, Industry News|Tags: HEOR, OrphanDisease, research, therapeutics|
With the spinoff of its consumer healthcare operations into the new company Haleon, GSK is turning its focus onto new [...]
Compliance Congress for Specialty Products
Sydney Otomancek2022-06-10T16:15:17-04:00June 10th, 2022|Categories: Featured, Industry News|Tags: HEOR, OrphanDisease, pharma, raredisease, therapeutics|
Specialty pharmaceutical companies face significant regulatory and industry barriers while attempting to provide therapies for rare, complex, or orphan diseases. [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication